Abstract | In addition to recurrent pain, fatigue, and increased rates of physical disability, individuals with rheumatoid arthritis (RA) have an increased prevalence of some mental health disorders, particularly those involving affective or mood disturbances. This narrative Review provides an overview of mental health comorbidities in RA, and discusses how these comorbidities interact with disease processes, including dysregulation of inflammatory responses, prolonged difficulties with pain and fatigue, and the development of cognitive and behavioural responses that could exacerbate the physical and psychological difficulties associated with RA. This article describes how the social context of individuals with RA affects both their coping strategies and their psychological responses to the disease, and can also impair responses to treatment through disruption of patient-physician relationships and treatment adherence. Evidence from the literature on chronic pain suggests that the resulting alterations in neural pathways of reward processing could yield new insights into the connections between disease processes in RA and psychological distress. Finally, the role of psychological interventions in the effective and comprehensive treatment of RA is discussed.
. The relationship between RA and psychological fac tors is evident both from the altered prevalence rates of some psychiatric disorders causing affective disturbance in patients with RA versus the general population, and from the close links between physiological and psycho logical mechanisms that underlie these comorbidities. In this Review, we examine the extant literature on psychia tric comorbidities in RA and explore the relationships between characteristics of RA and psychosocial, physio logical, and neural factors. We discuss these data in the context of effective adaptation to RA, delineating the processes that could protect affected individuals against the declines in physical and psychological functioning that commonly occur with progression of RA. We also describe the importance of social context in the experi ence of living with RA, and the role of social factors in the effective treatment of RA.
Psychiatric comorbidities
In communitybased adults under the age of 45 years, having arthritis is a risk factor for the development of a mental health disorder in later life 2 . Although the converse is not true (having a mental health condition does not reliably predict the later development of arthritis) 2 , mental health disorders are associated with adverse healthrelated outcomes such as pain, disabil ity, and impaired quality of life in patients with RA 3, 4 . Compared with individuals without recurrent pain or physical illness, patients with RA have worse outcomes in several healthrelated quality of life domains, includ ing increased psychological distress, decreased quality of sleep, and increased use of passive paincoping strat egies 5 . Although prevalence rates for all psychiatric dis orders are not consistently elevated in individuals with RA (for example, evidence of an increased prevalence of substance abuse or eating disorders is absent), mood disorders seem to be considerably more common in individuals with RA than in the general population 6, 7 .
Depression
The psychiatric condition most commonly associated with RA is depression 6 . A metaanalysis of 72 studies on depression in individuals with RA found a prevalence of roughly 16 .8% for major depressive disorder 7 , although the estimated prevalence varied substantially between studies, attributed to differences in measurement meth odologies. Prevalence estimates can also be affected by differences in the course and recurrence of depressive symptoms, which vary greatly from person to person 8, 9 . Furthermore, many individuals with RA experience clinically significant depressive symptoms (results from the previously mentioned systematic review suggest that prevalence estimates range from 14% to 48%), but do not meet the full diagnostic criteria for major depressive disorder 7 . From a clinical standpoint, comorbid depression is associated with increases in several adverse outcomes in patients with RA, including pain, inflammation, and disability 10 . Depression seems to decrease adherence to medical treatment 11 and is associated with increased dis ability 4, 12 , impaired quality of life 13, 14 , and reduced rates of clinical remission of RA symptoms and treatment response [15] [16] [17] . Patients with moderate or severe depres sion are less likely than those with mild or no depression to adhere to medical recommendations across a variety of medical conditions, including RA 11 . This association might be attributable to feelings of hopelessness or to a positive feedback loop in which nonadherence leads to a worsening of physical symptoms, thereby further increasing depression 11 . Patients with RA who have chronic depression might be more likely than those with milder or subclinical levels of depression to discontinue DMARDs against the recommendations of their health care providers 17 . Depressionrelated reductions in treat ment adherence could also be partially attributable to social withdrawal, a common correlate of depression that can compromise the efforts of supportive family members and friends to encourage patients to engage in selfcare 11 . Furthermore, depression in RA is often coincident with other physical health problems 18 , and is associated with increased mortality 19 and an increased risk of specific adverse outcomes, such as myocardial infarction 20 and suicide 21 .
Anxiety
Anxiety disorders are common in patients with RA 22 , and some estimates suggest that anxiety symptoms occur even more frequently than depression in indi viduals with arthritis 23 . One study found a 16% lifetime prevalence of anxiety disorders in individuals with RA 24 , and in an analysis of survey data, an estimated 11.2% of patients with arthritis reported panic attacks and 5.6% reported receiving a diagnosis of generalized anxiety disorder 25 , although the latter study did not delineate between patients with RA and patients with other forms of arthritis. Symptoms of anxiety are more common in individuals with RA who have comorbid major depression than in either patients with RA in general or agematched healthy individuals 26 . This pattern of findings is unsurprising, given the overlap between depression and anxiety in clinical and empir ical studies 6 . As with depression, symptoms of anxi ety also correlate with impaired healthrelated quality of life 27 and poor responses to medical treatment in patients with RA 15 .
Post-traumatic stress disorder
Posttraumatic stress disorder (PTSD) has been pro posed as a risk factor for developing RA in adulthood above and beyond the effects of familial and genetic fac tors 28 . Notably, PTSD can exacerbate RA, as comorbid PTSD in patients with RA is associated with poor patientreported outcomes and an increased number of tender joints 29 . However, only a few studies have demonstrated a relationship between PTSD and RA, and these have been conducted almost exclusively in veterans 28, 29 (among whom the incidence of PTSD is decidedly more common than in the general popula tion 30 ). Consequently, whether this evidence reflects a true interaction between RA and PTSD, or whether the reported association is due to characteristics specific to individuals with a history of military service (such as combat exposure) remains unclear 30 .
Schizophrenia
In contrast to the increased rates of mood disorders, rates of schizophrenia seem to be decreased in individ uals with RA compared with the general population 31, 32 . A prevailing explanation for this phenomenon concerns the aberrant inflammatory cytokine profile of individ uals with schizophrenia 33, 34 , which features increased levels of markers of immune cell activation, including soluble IL2 receptor 33 and increased circulating levels of proinflammatory cytokines, such as IL6 (REF. 34 ). Notably, high blood concentrations of IL1 receptor antagonist, an antiinflammatory cytokine that could have protective effects against RA 35 , are also found in individuals with schizophrenia 33 . These differences in immune function might reflect factors only peripher ally related to RA or schizophrenia (such as the presence of specific genetic variants 31 , longterm use of medica tions that alter glutamatergic signalling 31 , or an elevated reactivity to stress 33 ). Nevertheless, current evidence suggests that these profiles of altered immune responses in RA and schizophrenia contribute to a degree of mutual exclusion in these disorders, that these inflam matory processes are complex and mutually influen tial, and that understanding their interactions requires increased knowledge of their underlying processes and consequences.
Key points
• Individuals with rheumatoid arthritis (RA) demonstrate an increased prevalence of mood disorders compared with the general population, but a decreased prevalence of schizophrenia, probably due to alterations in inflammatory processes • Several mechanisms underlie the relationship between RA and mental health comorbidities: cognitive, behavioural and affective responses, inflammatory processes, and fatigue • Social factors have important implications in psychological reactions to RA, and could also be involved in pain processing and RA disease activity • Neural reward-processing deficiencies are an emerging area of inquiry in understanding the relationship between pain and psychological states that warrants additional attention in patients with RA • Psychological treatments that increase active coping strategies, ameliorate affective distress, bolster self-efficacy, and increase supportive social relationships could improve treatment outcomes in patients with RA Nature Reviews | Rheumatology 
Mood
Mechanisms of affective disturbance Several mechanisms are thought to link RA with over all psychological functioning, including cognitive, emotional, and behavioural reactions to having RA 10 , and psychological reactions to RArelated physical symptoms, such as pain intensity, fatigue, and altered inflammatory responses 36 . Of note, the mechanisms connecting RA and mental health are likely to be mutu ally influential, making the outcome of these mecha nisms inconsistent across patients and situations. For example, emotional distress could be accompanied by an underlying physiological stressor, such as inflam mation, which, if sustained, could compromise phys ical function, thereby exacerbating emotional distress (FIG. 1) .
Physical symptoms
The physical symptoms of RA, including pain, inflam mation, and fatigue, have important implications for the mental health of affected patients. Chronically impaired physical states can change neural processing and thereby adversely affect mental health (discussed later in this Review). A substantial body of literature also suggests that patients with RA demonstrate abnor malities in hypothalamic-pituitary-adrenal (HPA) axis responsivity 37 . Patients with RA have altered levels of circulating hormones (such as testosterone), dampened cortisol release in response to stressors, desynchroni zation of cooperative signalling between the HPA axis and autonomic nervous system, and increased levels of circulating proinflammatory cytokines 38 , which collec tively contribute to differences in immune function that, in turn, affect psychological states 37 .
Stress. Stress is a key link between HPA axis abnormal ities and mental health in RA. Some evidence suggests that a decline in cooperative signalling between the HPA axis and sympathetic nervous system, resulting from chronic activation of the sympathetic nervous system and impaired regulation of acute physiological responses to stress, might make patients with RA who experience stress particularly susceptible to chronic inflammatory states 38 . Thus, stress itself has been identified as an aggra vating factor for RA 39 . As the results of two metaanalyses have identified increased circulating levels of proinflam matory cytokines in patients with depression 40, 41 , we might reasonably expect some of the mood dysregula tion seen in patients with RA to be directly attributable to chronic inflammation. However, relationships between stress and inflammation in RA have been observed pri marily in crosssectional or shortterm studies, and addi tional longitudinal studies are needed to verify whether chronic inflammation has implications for longterm mental health in patients with RA 38 . Rheumatic disease has itself been characterized as a stressor. A patient's reaction to having a rheumatic disease can, therefore, have substantial implications for their mood and continued physical and psychosocial By contrast, patients with RA who have strong belief in their ability to function and manage their disease are likely to adopt healthy behavioural coping approaches. The extent to which patients adopt healthy and active coping responses to RA affects their subsequent attitudes to medical intervention and their ability to self-manage RA, which can then feed back into the severity of the disease itself. Clustering of physical and psychological factors is also evident, such as coincident depression and fatigue states and inflammatory episodes concurrent with periods of high stress levels and negative emotion, suggesting that these processes interact in complex ways. function 42 . For example, individual differences in stress reactivity and pain intensity can predict the severity of depressive symptoms in patients with RA 43 . Likewise, the degree of functional impairment due to RArelated pain and disease processes is positively correlated with rates of depression and anxiety 44, 45 . As a related point, one of the key determinants of longterm quality of life in patients with RA seems to be ongoing pain 46 . Recurrent pain is a key barrier to function for patients with RA, and how this pain is cognitively interpreted by a given individual can have major implications for their mental health. Consequently, processes driving stress responses in individuals with RA might be insidious and self sustaining; as stress associated with living with RA mounts, the dysregulation of physical processes already inherent in RA can persist or worsen.
Fatigue. Another key determinant of RArelated out comes is fatigue; up to 80% of individuals with RA are considered to experience clinically significant fatigue 47 , which greatly impairs both their quality of life 27, 48, 49 and their physical functioning 48, 50 . Furthermore, fatigue seems to have a complex aetiology involving pain intensity 47 , RA disease activity 51 , inflammatory pro cesses (which could result in enhanced pain process ing) 52 , and concurrent affective mood disorders, such as distress 53 or depression 15, 54 . However, considerable debate is ongoing about the mechanisms leading to fatigue in RA; the results of some studies suggest that fatigue occurs independently of RA disease activity 7, 50 , whereas other observations suggest that fatigue might be mediated by inflammation 51 and could, therefore, be treated with DMARDs (which also reduce pain and dis ease activity) 47 . By contrast, several studies have clearly shown close relationships between fatigue, psychologi cal distress 55 , and depression 15, 36, 53, 56, 57 . The link between depression and fatigue is unsurprising, as fatigue is a common correlate of depression, even among individ uals without a rheumatic disorder 58 . Notably, fatigue and mood might influence each other; on days of high fatigue levels, individuals with RA report having higher levels of negative mood and lower levels of positive mood 59 . Conversely, the deleterious effects of fatigue on mood could be attenuated by behavioural responses, as individuals who report high levels of physical activity have a more positive mood on days of high fatigue 59 . The relationship between emotion and fatigue is complex, however, and individuals with RA who report frequent positive interpersonal events might still experience increased fatigue the following day 60 . The concurrence of both positive and negative interpersonal events might be the most meaningful factor in determining future fatigue states 61 . Considerable debate is also ongoing about whether symptoms traditionally considered to be medically unexplained, for example those related to suspected cen tral nervous system sensitization (such as fibromyalgia or chronic fatigue syndrome, which cooccur with RA), should be classified as mental disorders. The results of a metaanalysis suggest that such symptoms cannot be fully explained by psychological factors 62 . Nonetheless, patients with RA and comorbid chronic fatigue syndrome are more likely than patients with RA alone to attribute their somatic symptoms to unknown dis ease processes, and to have poorer overall views of their health, which might increase their likelihood of future disability 63 .
Emotional status
Emotional health is a key contributor to patient adap tation to life with RA. Ongoing mood problems in patients with RA, such as those noted in the sections on depression and anxiety, predict increased pain intensity 64 and decreased function 9 . Conversely, positive emotions seem to buffer the relationship between pain and nega tive emotions 65 , and are associated with decreased pain intensity over subsequent days or weeks 66 . However, pos itive emotional systems might be impaired in individu als with RA and comorbid depression, in part owing to decreased engagement in activities that promote positive emotions 43 .
To some extent, the emotional consequences of RA are attributable to the reductions in function caused by RArelated symptoms. Individuals with RA and comorbid depression report reduced quality of life, and quality of life parameters more closely reflect the degree of impaired physical function in these individuals than does their typical level of pain 45 . Furthermore, the presence of both RA and depression might contribute to increased dysregulation of mood. Studies of daily diaries suggest that patients with RA and a history of depression (who are in most respects indistinguishable from individuals with RA but no history of depression) demonstrate a greater degree of paincontingent emo tional wellbeing at the daily level 67 . Specifically, individ uals with RA and a history of depression demonstrate lesseffective coping strategies, show larger decreases in wellbeing during times of increased pain, and report feeling less in control of their pain when emotionally distressed, than do patients with RA who have no his tory of depression 67 . These findings suggest that, in these individuals, depression could contribute to the increased emotional distress related to their RA symptoms, in part because of passive behavioural and cognitive responses that prioritize avoidance or shortterm amelioration of pain and distress over personally meaningful functional goals, which can compromise longterm health.
Cognitive responses
A patient's appraisal of their diseaserelated difficulties (for example, increased pain or reduced physical func tion) is a crucial determinant of concurrent emotional states 68 . Pain catastrophizing, a pattern of negative cog nitive appraisal characterized by feelings of helplessness, ruminative thoughts, and a tendency to magnify the negative consequences of pain, is an important predictor of poor physical and psychological outcomes in patients with RA 69 . Pain catastrophizing is more common in indi viduals with RA than in healthy individuals, and pre dicts increases in pain severity, inflammatory activity, and levels of disability 10 . Appraisals of overall health and functional ability also have implications for mood:
Cognitive styles
Relatively stable patterns of cognitive interpretation of events that have implications for behaviour and mood, such as an increased tendency towards catastrophic appraisal of pain or health, or optimistic views of oneself, health, or future function.
individuals with RA who perceive their health to be poor and who view themselves as disabled tend to have ele vated levels of depression 70 and reduced healthrelated quality of life 71 . Conversely, some cognitive styles are pro tective against the deleterious effects of RA. For example, individuals who report being optimistic or accepting of their pain have increased resilience to pain, and are less likely to have high levels of physical dysfunction in the early stages of RA than pessimistic and nonaccepting patients 72, 73 . Similarly, feelings of selfefficacy and con fidence in one's ability to manage ongoing physical symptoms are predictive of reduced pain, increased goal achievement, and improved quality of life 74 . Individuals who engage in healthy coping strategies, such as re appraisal of unrealistic or distressing negative thoughts, also show good overall coping and report increased qual ity of life and decreased levels of helplessness related to their RA symptoms 71 .
Behavioural responses
Different trajectories of adjustment to living with RA also contribute to the degree to which RArelated symp toms compromise patients' efforts at effective coping and healthy behaviour 10 . Passive coping styles, such as isolat ing oneself or adjusting behaviour to avoid the experi ence of pain, increase the likelihood of future functional impairment in patients with RA 75 . Conversely, active coping styles, such as using effective problemsolving strategies or increasing physical activity, seem to con fer psychological health benefits 71 . Patients' behavioural coping responses to RA are closely related to how they view their illness; as noted previously, individuals who view their pain or their disease as uncontrollable or cat astrophic are less likely than patients with positive views to cope effectively with their physical symptoms 10, 70, 71 . As a result, the affective, cognitive, and behavioural responses of people with RA are closely linked.
Reward circuitry and neural processing
In the search for mechanisms to explain interindividual variability in RArelated pain and mental health, one worthwhile option to consider is the biobehavioural view that adaptation to pain is governed by the mesolim bic dopaminergic reward system. Given the paucity of data from patients with RA on this topic, we draw upon research in other chronic pain disorders. Dopamine neurotransmission is altered in patients with fibromyal gia [76] [77] [78] , a disorder characterized by chronic widespread pain, fatigue, sleep disturbance, and dysregulation of emotion. Specifically, these patients have reduced lev els of dopamine metabolites in the cerebrospinal fluid, presumably reflecting a reduced rate of postsynaptic phasic dopamine firing 79 . Furthermore, imaging stud ies using PET indicate that patients with fibromyalgia have lower basal levels of presynaptic dopamine 77 , and release less dopamine in the basal ganglia in response to a tonic pain challenge 78 , than do healthy individuals. In a separate analysis of PET data from the same sample of patients, an index of presynaptic dopamine metab olism, estimated through a region of interest analysis of nuclei within the ventral tegmental area, correlated positively with reduced cortical grey matter volume 76 . Positive emotions are strongly linked to increased dopa mine neurotransmission and other activity within the mesolimbic reward system 80, 81 , making these findings particularly striking against the backdrop of studies demonstrating that patients with fibromyalgia demon strate a pattern of affective dysregulation characterized by deficits in positive emotional responses 82, 83 . Chronic back pain has also been associated with rewardsystem alterations. The nucleus accumbens, which is the primary afferent terminal of dopamine within the mesolimbic region, is deactivated during a pain challenge in patients with chronic back pain com pared with healthy controls 84 . Furthermore, PET studies suggest that activation of dopamine receptors D2 and D3 in the nucleus accumbens during a pain challenge is reduced among patients with chronic back pain com pared with healthy controls 85 . Interestingly, reductions in dopamine neurotransmission in the ventral striatum are correlated with positive mood 85 . Taken together, these data suggest that chronic pain is associated with abnor malities in dopamine neurotransmission that seem to be involved in processing both nociceptive signalling and the affective component of pain.
Pain in RA is distinct from chronic back pain and fibromyalgia in several respects, perhaps most nota bly in the prominent contribution of proinflammatory cytokines to RArelated pain. Thus, attempts to under stand potential interactions between the reward system and pain in RA require an appreciation of how inflam matory processes might contribute to that association. Indeed, the inflammatory milieu inherent in RA might influence both the functioning of the reward system and accompanying behaviours. Proinflammatory cytokines broadly modulate the function of neurotransmitters (including dopamine) at multiple levels, via the acti vation of metabolic and epigenetic processes that alter neurotransmitter synthesis, reuptake and release 86 . Additionally, endotoxininduced inflammation seems to promote both depressed mood and decreased ventral striatal responses to monetary reward cues 87 , extending previous evidence suggesting that proinflammatory cytokines worsen depressed mood 88 . Similarly, typhoid vaccination of healthy individuals resulted in an increase in IL6 levels, which attenuated the reduction in activa tion of the substantia nigra usually seen during a cogni tive attention task 89 . A candidategene analysis in patients with cancer revealed that a variant in the gene encoding IL4, another proinflammatory cytokine, predicts a cluster of pain, fatigue, sleep disturbance, and depressive symp toms 90 , a complex of symptoms also commonly observed in patients with RA 91, 92 and individuals with dopamine signalling abnormalities 93 . The existence of pathways linking inflammation to the functioning of the reward system provides a com pelling framework for understanding adaptation to RA. For example, patients with chronic inflammatory con ditions (which are partly due to the HPA axis alterations discussed earlier) can experience alterations in dopa minergic neurotransmission that have the potential to impair behaviour (FIG. 2) . Because dopamine critically 
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Insecure attachment
A stable cognitive and behavioural style of forming and maintaining meaningful social relationships, characterized by high levels of anxiety and hypervigilance to cues about whether an individual is loved by significant others to whom he or she is attached.
Therapeutic alliance
The relationship between a patient and his or her clinical provider (e.g. physician or psychologist), which has implications for treatment adherence and treatment outcomes, and might evolve over time.
regulates positive emotions and motivation 80, 81 , aberrant functioning of the mesolimbic dopaminergic reward system could lead to patterns of behavioural responses that increase a patient's longterm risk of physical or psychological dysfunction by constricting their range of positive coping resources.
Social factors
Social factors could add valuable detail to models of physio logical and psychological processes in RA, but have been underemphasized in traditional views of stress and pain 94 . The context in which pain occurs might alter how it is experienced 95 . Context might also interact with cognitive and neural states to alter a patient's response to medical intervention 95, 60 . Interpersonal stressors, such as daily neg ative interpersonal events, contribute to acute increases in inflammatory activity 96, 97 , which could have implications for fatigue states 97 . Similarly, frequent positive or enjoya ble interpersonal events are predictive of reduced levels of fatigue and high concurrent levels of positive emotion 60, 98 .
The frequency of negative daily interpersonal events is positively correlated with levels of RA disease activity 99 , as well as with concurrent emotional distress and fatigue 60 . Thus, the frequency with which individuals engage with others in their social environment could have implications for overall physical and psychological health. However, the presence of RA could substantially alter these patterns of social engagement; for example, women with RA show evidence of decreased social activity over time compared with healthy women 100 . Conversely, interventions that increase patterns of social engagement are efficacious in increasing wellbeing as well as reducing disease activity, although evidence that these effects are sustained across time is lacking 100 . Social engagement patterns are shaped through out a person's life, beginning in childhood long before inflammatory processes associated with chronic pain emerge 101 . Hypervigilance and other fearrelated motiva tional states have been associated with high levels on the anxiety dimension of insecure attachment 102 . Differential responsiveness to social reward and high reactivity to social stressors have been identified among individu als with a history of abuse 103 , and a reduction in ventral striatum activation following social rewards has been found in those with insecure attachment characterized by avoidance 104 . A history of child abuse and attachment insecurity, as well as contemporaneous social factors, could set the stage for future disability and impair both physiological and psychological processes associated with resilient adaptation to chronic pain 97, 105, 106 . The quality of extant relationships also seems to have important implications for psychological adjust ment to RA (FIG. 3) . A high frequency of negative mar ital interactions related to the disease seems to impair the adjustment processes of both members of a roman tic relationship in which one partner has RA 107 , and to worsen both the perceived impact of RA and the patient's concurrent psychiatric symptoms 108 . Conversely, support ive relationships bolster the patient's longterm resilience against stress and other challenges 109 . High levels of per ceived support from their spouse predict increased use of active coping responses in patients with RA 110 , and seem to protect against psychiatric comorbidity 111 and support the longterm retention of physical function 112 . Emotional support might also buffer against the emotional impact of disability due to RA 113 .
Relationships with care providers
Patient-careprovider relationships are another impor tant predictor of wellbeing in RA. Optimal care is reli ant upon physician-patient relationships that are built on trust and that actively encourage patient participation in treatment and healthcare decisions 114 . High levels of patient engagement in care are associated with superior health outcomes and healthrelated quality of life 115, 116 , high levels of treatment satisfaction 115 , and increased treatment adherence 116 . In patients with RA, the deci sion to take antirheumatic medications is associated with trust in the physician 117 , suggesting a direct link between therapeutic alliance and adherence to medical recommendations. Rheumatoid arthritis (RA) contributes to chronic inflammatory states in part through dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, which manifests in altered physiological responses to stress, such as downregulation of normal anti-inflammatory responses after stress, and increased sympathetic tone at rest but decreased sympathetic response during stress. Chronic inflammatory states can alter dopamine transmission in the brain (resulting in lower basal levels of presynaptic dopamine, decreased dopamine release from basal ganglia in response to pain states, and decreased D2 and D3 receptor activation in the nucleus accumbens). In turn, these changes enhance pain processing and dampen positive affective responses. A reduction in positive emotional states can manifest as both increased depression and decreased motivation, thereby impairing otherwise healthy coping responses and potentially affecting disease-relevant behaviour, such as exercise, treatment adherence, and social withdrawal or conflict. These factors can adversely affect RA disease processes in the future. Additionally, the presumed downstream increases in emotional distress that can occur with declines in physical health and function subsequently contribute to chronic inflammatory states via the aforementioned changes in physiological stress processes. Nature Reviews | Rheumatology The complexity of psychological factors in RA might adversely affect the working relationships of patients with their physicians. One key factor is concurrent psychologi cal distress, most notably symptoms of depression, which can substantially worsen treatment outcomes 118 . Detection of depression in RA is difficult, however, for several rea sons: the fact that RA symptoms mimic depression, the reluctance of rheumatologists to assess depression, and systematic constraints such as a lack of time in clinic visits 119 . Other contributory factors include the dearth of research on how to recognize and manage depression in rheumatology clinics, and the inadequate dissemina tion of efficacious treatments for patients with RA who have depression into care practices 119 . Rheumatologists also seem to discuss depression infrequently with their patients: in a sample of 200 patients with RA, 21 (11%) had moderate or severe symptoms of depression, but only four (19% of the depressed patients) discussed depression during their rheumatologist visit 120 . Similar issues have been noted with other related symptoms; the results of one study showed that rheumatologists do not adequately address patient concerns about fatigue 121 .
A disconnect between the patient and rheumatol ogist could have major implications for therapeutic alliance and the effectiveness of future interventions; rheumatologists who lack awareness of patients' experiences of psychological distress, pain, and fatigue are unlikely to have a shared understanding with their patients about disease status 122 . Consequently, optimal clinical care involves treating both RA disease processes and the psychological factors that can modulate those pro cesses, both directly (through shared mechanisms) and indirectly (through behaviours that facilitate or impair treatment adherence) 123 .
Implications for treatment
Given the importance of psychological factors in RA, a clear need exists to complement existing medical treatments with psychological interventions
. Among the most prominent interventions is cogni tivebehavioural therapy (CBT), which utilizes behav ioural and cognitive principles to improve function and manage stress and negative emotions. This approach has demonstrated efficacy in improving several aspects of patient functioning, including depression, fatigue, medication adherence, and perceptions of social sup port 124 . However, disease stage seems to be a key factor in response to CBT, such that individuals in advanced stages of RA might not benefit to the same extent as do those in early stages of the disease 125 . . Individuals who maintain optimistic perspectives or high levels of self-efficacy are more likely (than individuals with pessimistic perspectives or low self-efficacy) to sustain healthy repertoires for coping with RA, and are less likely to show pronounced adverse psychological reactions to the physical symptoms caused by RA. Additionally, the broader social environment can impact a patient's psychological reactions to RA; patients in supportive environments seem to be more resilient against RA-related declines in physical and psychological function, whereas those in stressful environments show elevated physical symptoms, reduced function, and poor psychological adjustment to RA. Individuals with RA can also adversely influence their immediate social environments via behavioural coping responses such as self-imposed isolation or initiating conflict with others when pain or frustration levels are high, which could then have consequences for future emotional states.
A nascent, but promising, body of evidence suggests that meditationbased approaches, such as mindfulness based stress reduction (MBSR) might also bolster psy chological health in RA. MBSR is an intervention based on Buddhist principles of nonreactivity, promotion of awareness and purposeful action that has demonstrated promise in the effective treatment of depression and anxiety disorders 126 , chronic health conditions 127 , and chronic pain disorders 128 . Although only a few studies of MBSR have been conducted in patients with RA, their results suggest that MBSR is effective in improving patients' wellbeing 129 , reducing their psychological dis tress 129 and decreasing their pain intensity 130 . However, current evidence suggests that the benefits of MBSR do not directly affect RA disease activity 129 . Unfortunately, not all patients with RA have access to therapists trained in these psychological approaches (such as clinical psychologists). Consequently, alterna tive approaches, such as selfmanagement programmes, have become increasingly important in the treatment of RA 131 . One such approach, the Arthritis SelfManagement Program [132] [133] [134] , is effective in improving several clinical variables, including selfefficacy, health behaviours, and decreased medical utilization (specifically, a reduced frequency of physician visits). The Arthritis Self Management Program also seems to reduce the financial burden of RA care 133 . Given the apparent costeffectiveness, low financial burden and efficacy of these interventions, they seem to be a suitable option for many patients with RA for whom consultation with a trained mental health care provider is either undesired or unfeasible.
Future directions for research
As noted previously, reducing the feelings of social dis connection and stigmatization that can accompany a diagnosis of RA, and fostering good treatment alliances between patients, their families, and their healthcare pro viders, could yield improved outcomes in patients with RA. Interventions that attend to the bidirectional interplay between these social factors and physical pain 135 , and that enhance awareness of the roots of patients' perceptions of disregard on the part of their medical providers, and mindsets that promote stereotyping, distrust and social isolation 136 are especially worthwhile, and fill a gap in the current behavioural approaches. Similarly, interventions combining pharmacotherapy and psychotherapy have shown promising preliminary results in treating depres sion in patients with arthritis 137 , but remain a relatively poorly studied area overall. We urge further research attention in this area as potentially valuable to future outcomes in rheumatological care. Additionally, despite compelling evidence of reward deficiencies in several chronic pain conditions 84, 85 , this area has not been given adequate attention in patients with RA. The examination of rewardprocessing abnormalities in patients with RA is expected to be instrumental in fostering improved understanding of the interplay between physical disease processes and mental health difficulties in this disease.
One potential avenue for future research is the utili zation of experimental designs that manipulate inflam matory states in patients with RA. Experimental sleep deprivation, for example, reliably increases levels of pro inflammatory cytokines in healthy individuals 138, 139 , and also increases pain, fatigue, depressive symptoms, and disease activity in patients with RA 140 . In the light of evidence that both insomnia 141, 142 and experimental sleep deprivation 143 attenuate positive emotions, an intriguing next step might be to examine proinflammatory cytokines as potential mediators of the effects of sleep deprivation on behavioural and neural markers of reward system function.
Conclusions
Meaningful discussion of the interplay between physical and psychological processes in RA requires an under standing of the many levels at which this interaction could occur. Thus, a patient's adaptation to RA must be understood within their overall social context, as the presence of interpersonal stressors and support can have shortterm and longterm implications for phys ical health, coping strategies, and treatment responses. Future models that integrate different levels of analysis into a holistic approach could yield useful empirical and clinical insights. For example, consideration of not only physical examination findings and laboratory results, but also the psychosocial factors unique to each patient, could yield improvements in the efficacy of current treat ments, slowing disease activity and promoting longterm psychological health and physical function.
Box 1 | Psychological interventions for rheumatoid arthritis
Cognitive-behavioural therapy Combines principles of cognitive restructuring (identification and reframing of distorted patterns of thinking into more-adaptive and less-distressing thoughts) and behavioural techniques designed to manage stress, increase physical activity, and increase active coping (for example relaxation techniques, activity pacing approaches, and goal setting).
Mindfulness-based stress reduction
Meditation-based approach, designed to treat chronic pain using Buddhist principles by reducing reactivity to emotions, fostering acceptance of physical and psychological states and engaging in mindful and purposeful action. Typically taught as a 10-week course involving several types of meditation, including training of attentional processes (by focusing on the breath and bodily sensations), and being mindful of activities in daily life such as eating or walking. Daily meditation practice is emphasized as a key component of treatment.
Self-management approaches
Typically delivered by trained laypeople or using internet-based platforms as a 6-week course, covering some principles included in CBT (such as relaxation, effective problem-solving, and goal setting), as well as education about the nature of the disease.
